Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schubert

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Clinical Pharmacokinetics|May 11, 2011
Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical dataMona Abdel-Tawab, Oliver Werz, Manfred Schubert-Zsilavecz
Current Medicinal Chemistry|June 13, 2009
Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicityMona Abdel-Tawab, Heiko Zettl, Manfred Schubert-Zsilavecz
Bioorganic & Medicinal Chemistry Letters|June 27, 2009
Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonistsHeiko Zettl, Ramona Steri, Michael Lämmerhofer, et al.
Antiviral Research|October 27, 2012
Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cellsPatchima Sithisarn, Martin Michaelis, Manfred Schubert-Zsilavecz, et al.
Expert Opinion on Therapeutic Patents|January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 18, 2017
Quantification of active ingredients in semi-solid pharmaceutical formulations by near infrared spectroscopyLisa B Schlegel, Manfred Schubert-Zsilavecz, Mona Abdel-Tawab
Journal of Medicinal Chemistry|November 29, 2021
The Medicinal Chemistry and Therapeutic Potential of LRH-1 ModulatorsAlisa Lang, Laura Isigkeit, Manfred Schubert-Zsilavecz, et al.
Expert Opinion on Therapeutic Patents|November 16, 2012
Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulatorsChristina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz, et al.
Retrovirology|December 24, 2005
Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4Zhiping Ye, George G Harmison, Jack A Ragheb, et al.
Journal of Diabetes Science and Technology|July 19, 2015
Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 RequirementsMona Abdel-Tawab, Mario Schmitz, Stefan Kamlot, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Clinical Pharmacokinetics|May 11, 2011
Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical dataMona Abdel-Tawab, Oliver Werz, Manfred Schubert-Zsilavecz
Current Medicinal Chemistry|June 13, 2009
Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicityMona Abdel-Tawab, Heiko Zettl, Manfred Schubert-Zsilavecz
Bioorganic & Medicinal Chemistry Letters|June 27, 2009
Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonistsHeiko Zettl, Ramona Steri, Michael Lämmerhofer, et al.
Antiviral Research|October 27, 2012
Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cellsPatchima Sithisarn, Martin Michaelis, Manfred Schubert-Zsilavecz, et al.
Expert Opinion on Therapeutic Patents|January 8, 2013
Novel prostaglandin receptor modulators--part II: EP receptor modulators; a patent review (2002 - 2012)Daniel Flesch, Daniel Merk, Christina Lamers, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 18, 2017
Quantification of active ingredients in semi-solid pharmaceutical formulations by near infrared spectroscopyLisa B Schlegel, Manfred Schubert-Zsilavecz, Mona Abdel-Tawab
Journal of Medicinal Chemistry|November 29, 2021
The Medicinal Chemistry and Therapeutic Potential of LRH-1 ModulatorsAlisa Lang, Laura Isigkeit, Manfred Schubert-Zsilavecz, et al.
Expert Opinion on Therapeutic Patents|November 16, 2012
Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulatorsChristina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz, et al.
Retrovirology|December 24, 2005
Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4Zhiping Ye, George G Harmison, Jack A Ragheb, et al.
Journal of Diabetes Science and Technology|July 19, 2015
Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 RequirementsMona Abdel-Tawab, Mario Schmitz, Stefan Kamlot, et al.
Pageof 15